HK inno.N, Hits Upper Limit on U.S. Phase 3 Success[K-Bio Pulse]

• 김지완
• 2025.04.25
• 오전 07:42

• LotteBiologics
• ADC
• cdmo

Lotte Biologics Signs First ADC Manufacturing Deal...Launches U.S. Plant

• 김승권
• 2025.04.24
• 오후 03:58

How MFC Rose to the Top in the Crowded API Market[Yoo Sung’s Pharma National Wealth Theory]

• 류성
• 2025.04.24
• 오전 08:35

• samsung
• k-bio
• cdmo

Samsung Biologics Sets Q1 Sales Record...Eyes KRW 5T Year

• 김승권
• 2025.04.23
• 오후 04:50

• HyundaiBio
• globaltrials
• universalantivirald

HyundaiBio begins global trials of universal antiviral drug

• 유진희
• 2025.04.23
• 오후 04:28

• Siilajen
• Vaxcell
• M2N

Sillajen Surge on FDA Nod, Patent Deal Vaxcell Bio Jumps[K-Bio Pulse]

• 송영두
• 2025.04.23
• 오전 07:40

• Sillajen
• K-bio

Sillajen Secures BAL0891 Patent Rights, Hits Limit Up

• 김승권
• 2025.04.22
• 오후 05:08

PeopleBio: Blood Test May Predict Post-Surgery Delirium

• 나은경
• 2025.04.22
• 오후 05:08

• SamsungBiologics
• CDMO

Samsung Biologics Celebrates 14 Years, Accelerates Global Top-Tier Growth<BR><BR>Now the world’s...

• 송영두
• 2025.04.22
• 오전 07:31

• Syntekabio
• AI
• Proteco

Syntekabio Partners with U.S. Proteco on Universal COVID Drug

• 송영두
• 2025.04.22
• 오전 07:31